Resveratrol IV Therapy

Intraveneous Resveratrol

Resveratrol is produced by many plants when they are stressed or under attack.  It is a constituent of red wine and provides and antioxidants resulting in a synergistic anticancer effect.  As oral absorption with supplementation is poor, I recommend the use the administration of resveratrol intravenously for cancer patients.

Based on my experience and research treating cancer patients, I have found that resveratrol can promote a proptosis of tumor cells and block tumor growth and migration.  It also prevents DNA damage that can lead to tumor formation.  In addition, resveratrol inhibits cyclooxygenase which is known to play a role in tumor genesis by promoting inflammation and cancer cell proliferation.

Resveratrol has also been shown to increase the activity of a variety of carcinogen detoxifying enzymes which is extremely important in both the prevention of cancer and treatment of cancer. It has been shown to decrease the incidence of breast cancer, colorectal cancer, liver cancer and others.

It also suppresses CD 133 stem cells and the W NT/B pathway

In 2012 Dr. Mena found that the mechanism of cell death is inhibition of autophagy flux with lysosomal membrane rupture of the cancer cell.  Thus killing itself.

Scroll to Top
Skip to content